Chih‐An Lin

Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma

T. Chou, Cheng-Wen Wu, E. Lin, 2016, Oncotarget.

Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling

Ker-Chau Li, Yih-Leong Chang, Shin-sheng Yuan, 2014, Nature Communications.

EGFR‐Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs

Hsuan-Yu Chen, Sung-Liang Yu, Pan‐Chyr Yang, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Acute Respiratory Distress Syndrome: A Prospective Observational Cohort Study

Chong-Jen Yu, Chao-Chi Ho, Ming-Terz Lin, 2010, Journal of the Formosan Medical Association.

Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer.

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2021, Cancer letters.

Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever*

Chong-Jen Yu, H. Tien, F. Hu, 2011, Critical Care Medicine.

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib

J. Shih, Chong-Jen Yu, Chao-Chi Ho, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

Ker-Chau Li, G. Chang, Hsiang-Yuan Yeh, 2020, Cancer Immunology, Immunotherapy.

Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors

Chun-Ta Huang, Chong-Jen Yu, Ching-Yao Yang, 2023, BMC Cancer.